5.650USD-11.72%Mkt Cap: 39.75M $P/E: —2d ago
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap39.75M $
Enterprise Value145.69M $
Revenue (TTM)33.86M $
Gross Profit19.65M $
Net Income (TTM)-358.73M $
Revenue/Share3.432 USD
Last Price5.650 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.95
PEG—
EV/EBITDA-0.54
EV/Revenue4.30
P/S1.20
P/B-0.20
EPS (TTM)-50.52
EPS (Forward)0.73
52W Range
2.61516% of range21.34
52W High21.34 USD
52W Low2.615 USD
Profitability
Gross Margin64.97%
Oper. Margin-373.49%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M $
CapEx (TTM)733.00K $
FCF Margin17.68%
FCF Yield15.06%
Net Debt103.00M $
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.08
Quick Ratio0.07
Book Value/Sh-29.5440 USD
Cash/Share0.4780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.69M
Insiders11.67%
Institutions8.53%
Short Interest
Short Ratio0.9d
Short % Float3.17%
Short % Out.2.50%
Shares Short175.54K
Short (prev mo.)163.99K
Technical
SMA 507.197 (-21.5%)
SMA 2006.843 (-17.4%)
Beta1.74
S&P 52W Chg18.16%
Avg Vol (30d)81.89K
Avg Vol (10d)42.08K
Technical Indicators
RSI (14)33.6
MACD-0.2517
MACD Signal-0.1557
MACD Hist.-0.0960
BB Upper7.395 USD
BB Middle6.711 USD
BB Lower6.028 USD
BB Width20.37%
ATR (14)0.5590 USD
Vol Ratio (20d)1.77x